CELLnTEC Introduces Higher Certified (HC) Media

  You can now experience a seamless transition from lab to clinical trials using CELLnTEC`s Higher Certified (HC) Media.   Read More >    

»

        Platform for Alternative Skin Tests for sustainable FUTURE science (PAST4FUTURE) CELLnTEC joins the PAST4FUTURE consortium to address organoids-based new research methods for skin diseases. Skin is the human body’s largest organ. Chronic, non-healing wounds are a […]

»

  Meet CELLnTEC representatives at the `Society for Investigative Dermatology (SID) Annual Meeting` in Portland (USA), between 18 – 21th May 2021.   Conference Link: SID USA 2022  

»

  Meet CELLnTEC representatives at the `Tissue Engineering and Regenerative Medicine` International conference in Krakow (Poland), between 28 June – 01 July 2022.   Conference Link: TERMIS 2022  

»

COVID-19 and Respiratory Diseases Research Tools

March 1, 2020

  Infectious diseases rank among the top respiratory system illnesses. The novel and resurfacing respiratory viral outbreaks have jeopardized public health and global economy. The coronavirus-associated epidemics like SARS (2003), MERS (2015), and COVID-19 (2019) have drawn attention to viral […]

> More

CELLnTEC launches 2D Co-culture starter kits

August 15, 2019

  You can now successfully establish co-cultures of keratinocytes with fibroblast or melanocytes using CELLnTEC`s New PR2D-CC or PR2D-KM starter kits, respectively. Read More >

> More

CELLnTEC appoints Thomas Schnibbe as Chief Executive Officer

January 8, 2018

Berne, Switzerland, January 8, 2018 – CELLnTEC Advanced Cell Systems is pleased to announce that Thomas Schnibbe, Ph.D, joined the company as Chief Executive Officer. Professor Eliane Müller, founder and President of CELLnTEC, says: “The board and me personally are […]

> More